Ocugen announced that Connie Collingsworth, former COO of the Bill and Melinda Gates Foundation, will join the Company’s Business Advisory Board. The BAB was established in June 2023 to assist in driving public/private partnerships with governments around the world; pursuing business collaborations, partnerships, and licensing opportunities; creating awareness of the Company’s differentiated capabilities; and promoting access to the Company’s therapies around the world.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCGN:
- Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board
- Ocugen announces update from Phase 1/2 trial of OCU400
- Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
- Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
- Biotech Alert: Searches spiking for these stocks today